以骨转移为首发表现的隐匿性甲状腺髓样癌(附1例报道及文献复习)
被引量：1
摘要
甲状腺癌是由数种不同生物学行为以及不同病理类型的癌肿组成,主要包括乳头状腺癌、滤泡状癌、未分化癌、髓样癌四种类型。甲状腺髓样癌占甲状腺癌的2%-5%,恶性程度中等常沿淋巴道及血道转移。发生骨转移者较少见。现将我院发现的一例以骨转移为首发表现的甲状腺髓样癌报道如下。
出处
《现代肿瘤医学》
CAS
2011年第9期1851-1852,共2页
Journal of Modern Oncology
参考文献9
-
1Mssrouri R,Mohammadine E,Benamr S,et al.Sternal metastasisfrom differentiated thyroid carcinoma:what management. JChir . 2009
-
2JC Sisson,YK Dewaraja,EJ Wizauer,TJ Giordano,AM Avram.Thyroid carcinoma metastasis to skull with infringement of brain: treatment with radioiodine. Thyroid . 2009
-
3Mucha SA,Kunert-Radek J,Pomorski L.Positron emission tomo-graphy（18FDG-PET)in the detection of medullary thyroid carci-noma metastases. Endokrynologia Polska . 2006
-
4Moutaouakil A,Baha AT,Amraoui A.Metastasis of medullar thyroidcarcinoma（case report). Bull Soc Belge Ophtalmol . 2003
-
5吴晓徽,陆汉魁,高云朝,袁志斌.骨代谢指标在分化型甲状腺癌骨转移中的临床价值[J].中华核医学杂志,2007,27(6):350-353. 被引量：5
-
6A Oudoux,PY Salaun,C Bournaud,L Campion,C Ansquer,C Rousseau,S Bardet,F Borson-Chazot,JP Vuillez,A Murat,E Mirallié,J Barbet,DM Goldenberg,JF Chatal,F Kraeber-Bodéré.Sensitivity and prognostic value of positron emission tomography with F-18-fluorodeoxyglucose and sensitivity of immunoscintigraphy in patients with medullary thyroid carcinoma treated with anticarcinoembryonic antigen-targeted radioimmunotherapy. The Journal of Clinical Endocrinology . 2007
-
7Bianciotto CG,Demirci HY,Shields CL,et al.Simultaneous eyelidand choroidal metastases 36 years after diagnosis of medullary thy-roid carcinoma. Ophthalmic Plastic and Reconstructive Surgery . 2008
-
8郭剑锋,陈福进,曾宗渊,杨安奎,宋明,李秋梨,邓莅霏.甲状腺髓样癌33例临床分析[J].中山大学学报（医学科学版）,2004,25(B07):333-334. 被引量：4
-
9康杰,樊友本.分化型甲状腺癌骨转移治疗进展[J].中华内分泌外科杂志,2009,3(3):190-193. 被引量：6
二级参考文献14
-
1余靖,邸立军,宛凤玲,勇威本.骨代谢生化指标诊断恶性肿瘤骨转移的临床意义[J].中国肿瘤临床,2005,32(20):1193-1196. 被引量：10
-
2Shoup M, Stojadinovic A, Nissan A, et al. Prognostic indicators of outcomes in patients with distant metastases from differentiated thyroid carcinoma. J Am Coll Surg, 2003, 197: 191-197.
-
3Fontana A, Pierre D. Markers of bone turnover in bone metastases. Cancer, 2000, 88: 2952-2960.
-
4Duda RJ, O'Brien JF, Katzman JA, et al. Concurrent assays of circulating bone gla-protein and bone alkaline phosphatase:effects of sex, age and metabolic bone disease. J Clin Endocfin Metab, 1988, 66:951-957.
-
5Chrapko BE, Nocun A, Golebiewska R, et al. Bone turnover markers and bone scintigraphy in the evaluation of the skeletal metastases. Nucl Med Rev Cent East Eur, 2005, 8:100-104.
-
6Ebert W, Muley T, Herb KP, et al. Comparison of bone scintigraphy with bone markers in lung carcinoma patients. Anticancer Res, 2004, 24:3193-3201.
-
7Paqani F, Francucci CM, Moro L. Markers of bone turnover: biochemical and clinical perspectives. J Endocrinol Invest, 2005, 28 Suppl 10: 8-13.
-
8Jung K, Lein M, Stephan C, et al. Comparison of 10 serum bone turnover markers in prostate carcinoma patients with bone metastatic spread: diagnostic and prognostic implications. Int J Cancer, 2004, 111: 783-791.
-
9Berruti A, Piovesan A, Torta M, et al. Biochemical evaluation of bone turnover in cancer patients with bone metastases. Br J Cancer, 1996, 73 : 1581-1587.
-
10Frenay M, Namer M, Boublil JL, et al. Value of urinary hydroxyproline and bone isoenzyme of alkaline phosphatase in the early detection and follow-up of bone metastasis in breast cancer patients. Bull Cancer, 1988, 75 : 533-539.
共引文献11
-
1张晋冀,薛峰,蔡芾,宋佳,李波,程雷,王洪江.隐匿性甲状腺癌并颅骨转移1例[J].大连医科大学学报,2010,32(5):611-612. 被引量：3
-
2邵清,沈美萍.家族性甲状腺髓样癌2例临床分析[J].实用临床医药杂志,2011,15(17):170-171.
-
3张学东,李保军,赵现斌,薛伟,张浩.^(131)I与放化疗治疗分化型甲状腺癌骨转移的疗效比较[J].河北医药,2013,35(17):2603-2604.
-
4安小利,王喆,邓敬兰,张经建,王妮,王云雅,汪静.^131I临床治愈儿童分化型甲状腺癌多发转移一例[J].中华核医学与分子影像杂志,2013,33(5):388-389. 被引量：3
-
5陈俏峰,黄循波,沈东杰,刘涛,王天翔.甲状腺乳头状癌伴远处转移的临床分析[J].外科理论与实践,2014,19(3):256-259.
-
6张杰.分化型甲状腺癌的CT表现[J].临床医学,2014,34(12):114-115.
-
7高云飞,邓维叶,陈艳峰,欧阳电,杨中元,李秋梨,李茵,王曦,张诠,杨安奎,郭朱明.甲状腺髓样癌预后相关因素分析(附118例报告)[J].中国实用外科杂志,2015,35(9):996-1000. 被引量：16
-
8赵菁,姚智敏,王亚军,张小丽,海涛,刘翠翠,康骅.以肱骨病理性骨折为首发症状的甲状腺癌1例报告并文献复习[J].中国医刊,2016,51(6):89-91.
-
9许晓宇,赖建平.131Ⅰ临床治愈分化型甲状腺癌伴气管侵犯一例[J].实用医学影像杂志,2019,20(3):322-324.
-
10胡杨科,王珂,吴胜东,黄静,房炯泽,陆才德.甲状腺髓样癌肝转移一例[J].肝胆胰外科杂志,2019,31(11):693-694.
-
1须可扬.隐匿性中央型肺癌的CT诊断及价值[J].中外医用放射技术,1999(11):79-80.
-
2顾玲,步荣发,袁晔,布静秋,高飞.31例上颌窦腺样囊性癌临床分析[J].口腔医学研究,2006,22(4):437-439. 被引量：9
-
3吴刚,刘永锋,张佳林,刘树荣.隐匿性乳腺癌11例诊治体会[J].中国实用外科杂志,1998,18(3):163-164. 被引量：9
-
4陈焕新,鲁瑞林.MMP-7在直肠癌中的表达及与神经浸润的关系[J].华西医学,2008,23(3):487-489. 被引量：4
-
5黎音,古丽娜尔,郭劲,韦新荣,田卫华,平小佳,沈宝茵.食管癌病人局部淋巴结隐匿性微小癌转移的免疫组化研究[J].新疆医学院学报,1995,18(3):152-155.
-
6杨春明.甲状腺癌诊断和治疗的进展[J].中国现代普通外科进展,1999,2(3):1-6. 被引量：7
-
7邱铝.隐匿性乳腺癌9例报告[J].交通医学,1999,13(3):369-369.
-
8刘薇.隐匿性乳腺癌5例分析[J].河南医药信息,1999,7(11):21-21.
-
9蔡仲达,周守群.隐匿性乳腺癌6例报告[J].福建医科大学学报,1999,33(4):444-445.
-
10孙毓桂,贺健.隐匿性乳腺癌2例报告[J].铁道医学,1996,24(6):379-379.
